-
1
-
-
0027530506
-
1,3-Diozolanylpurine nucleosides (2R,4R) and (2R,4S) with selective anti-HIV-1 activity in human lymphocytes
-
121241; note
-
(1993)
J Med Chem
, vol.36
, pp. 30-37
-
-
Kim, H.O.1
Schinazi, R.F.2
Nampalli, S.3
Shanmuganathan, K.4
Cannon, D.L.5
Aves, A.J.6
Jeong, L.S.7
Beach, J.W.8
Chu, C.K.9
-
2
-
-
0030050719
-
Pharmacokinetics of (-)-β-D-2,6-diaminopurine dioxolane and its metabolite, dioxolane guanosine, in woodchucks (Marmota monax)
-
210465; note
-
(1996)
Antimicrob Agents Chemother
, vol.40
, Issue.3
, pp. 642-645
-
-
Rajagopalan, P.1
Boudinot, F.D.2
Chu, C.K.3
Tennant, B.C.4
Baldwin, B.H.5
Schinazi, R.F.6
-
3
-
-
0005343974
-
Triangle Pharmaceuticals licenses anti-AIDS compounds from Emory Univ.
-
216900
-
(1996)
Emerging Pharmaceuticals
, vol.5
, Issue.6
, pp. 10
-
-
-
6
-
-
4243912166
-
Pharmacokinetics of dioxolane guanine (DXG) following administration of DXG and prodrug, (-)-β-D-2,6-diaminopurine dioxalane (DAPD), to rats
-
247083; note
-
(1997)
Antiviral Res
, vol.34
, Issue.2
-
-
Chen, H.1
Boudinot, F.D.2
Tang, A.3
Gao, Z.4
Schinazi, R.F.5
Chu, C.K.6
-
8
-
-
0006585873
-
Anti-HIV activity in the HuPBMC SCID mouse model of six novel nucleoside analogs: (-)-emtricitabine, (+/-)-emtricitabine, D-DAPD, D-D4FC, CS-92 CS-87
-
283971; Abs 33; note
-
(1998)
Int Conf Antiviral Res
, vol.11
-
-
Ussery, M.A.1
Wood, O.L.2
Kunder, S.C.3
Bacho, M.A.4
Broud, D.D.5
Papermaster, S.F.6
Hall, B.E.7
Ciavarella, A.8
Nielsen, C.J.9
Schinazi, R.F.10
-
11
-
-
0003373285
-
DAPD: A novel inhibitor of hepatitis B virus replication
-
319660; Abs 77
-
(1999)
Antiviral Res
, vol.41
-
-
Kiefer, L.L.1
Schinazi, R.F.2
Korba, B.3
Chu, C.K.4
Tennant, B.5
Hill, E.L.6
Begley, J.7
Lampert, B.8
Locarnini, S.9
Furman, P.A.10
-
12
-
-
0005345741
-
Emerging coactive therapies for HIV and HBV diseases
-
319956; SS 130
-
(1999)
Antiviral Res
, vol.41
, pp. 2
-
-
Moxham, C.P.1
-
16
-
-
0005310571
-
Triangle Pharmaceuticals reports of DAPD preclinical safety and antiviral activity against drug-resistant HIV strains - Data presented at 39th Annual ICAAC Meeting in San Francisco
-
341335; September 27
-
(1999)
Triangle Pharmaceuticals Inc Press Release
-
-
-
18
-
-
0032823357
-
Mechanisms of action and in vitro activity of 1′,3′-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants
-
360483; note
-
(1999)
Antimicrob Agents Chemother
, vol.43
, Issue.10
, pp. 2376-2382
-
-
Gu, Z.1
Wainberg, M.A.2
Nguyen, Ba.N.3
L'Heureux, L.4
De Muys, J.M.5
Bowlin, T.L.6
Rando, R.F.7
-
19
-
-
0034108712
-
Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir
-
365649
-
(2000)
J Viral Hepatitis
, vol.7
, Issue.2
, pp. 161-165
-
-
Ying, C.1
De Clercq, E.2
Nicholson, W.3
Furman, P.4
Neyts, J.5
-
23
-
-
0003297872
-
Clinical HIV supression after short term monotherapy with DAPD
-
381836; Abs 690; note
-
(2000)
ICAAC
, vol.40
-
-
Eron, J.J.1
Kessler, H.2
Thompson, M.3
Deeks, S.4
Arduino, R.5
Jacobsen, J.6
Sista, N.7
Quinn, H.8
Harris, J.9
Bigley, J.10
Rosseau, F.11
-
24
-
-
0005330043
-
Triangle Pharmaceuticals and Abbott Laboratories report drug candidate DAPD decreases viral load in patients infected with resistant virus when added to failing drug regimens - DAPD may provide new salvage therapy
-
382647; September 18; note
-
(2000)
Triangle Pharmaceuticals Inc Press Release
-
-
-
26
-
-
0032808063
-
Pharmacokinetics of (-)-β-D-dioxolane guanine and prodrug (-)-β-D-2,6-diaminopurine dioxolane in rats and monkeys
-
389968
-
(1999)
AIDS Res Hum Retroviruses
, vol.15
, Issue.18
, pp. 1625-1630
-
-
Chen, H.1
Schinazi, R.F.2
Rajagopalan, P.3
Gao, Z.4
Zhu, Z.5
Chu, C.K.6
McClaure, H.M.7
Boudinot, F.D.8
-
28
-
-
0001085332
-
Two novel antiviral agents, DAPD and L-FMAU, which are active against wild-type and lamivudine-resistant HBV
-
390080
-
(1999)
Hepatology
, vol.30
, Issue.4 PART 2
-
-
Chin, R.1
Torresi, J.2
Earnest-Silveira, L.3
Trautwein, C.4
Bock, T.5
Manns, M.P.6
Furman, P.A.7
Cleary, D.8
Locarnini, S.A.9
-
30
-
-
0005345742
-
The nucleoside reverse transcriptase inhibitor DAPD is active against resistant HIV-1 isolates from patients failing standard nucleoside therapy
-
396279; note
-
Third International Workshop on HIV Drug Resistance & Treatment Strategies, San Diego, CA, USA 1999
-
-
Borroto-Esoda, K.1
Mewshaw, J.2
Wakefield, D.3
Hooper, B.4
Jeffrey, J.5
Furman, P.6
McCreedy, B.7
-
31
-
-
0005315568
-
Short-term monotherapy of DAPD in HIV-infected patients
-
396281
-
(2000)
Antiviral Therapy
, vol.5
, Issue.SUPPL. 3
, pp. 7
-
-
Deeks, S.1
Kessler, H.2
Eron, J.3
Thompson, M.4
Raffi, F.5
Jacobson, J.6
Sista, N.7
Bigley, J.8
Rousseau, F.9
-
32
-
-
0002531497
-
DAPD: A novel inhibitor of HIV and HBV replication is active against drug-resistant viruses
-
396282; note
-
(2000)
Antiviral Therapy
, vol.5
, Issue.SUPPL. 3
, pp. 5
-
-
Furman, P.A.1
Chin, R.2
Borroto-Esoda, K.3
Mewshaw, J.4
Dent, B.5
Barthalomews, A.6
Locamini, S.7
-
33
-
-
0005315062
-
Anti-HIV activity and tolerability of DAPD, a novel dioxolane guanine RT inhibitor: Preliminary results of a phase I/II clinical trial
-
396283; Abs TuPpA1146; note
-
13th International Aids Conference, Durban, South Africa 2000
-
-
Kessler, H.1
Eron, J.2
Thompson, M.3
Raffi, F.4
Jacobson, J.5
Deeks, S.6
Richman, D.7
Sista, N.8
Borroto-Esodo, K.9
Bigley, J.10
Rousseau, F.11
-
34
-
-
0005275293
-
Anti-HIV activity of DAPD in treatment-naive and treatment-experienced subjects
-
397063; ; Abs PL6.6; note
-
Fifth International Congress on Drug Therapy in HIV Infection, Glasgow, UK 2000
-
-
Raffi, F.1
Kessler, H.2
Thompson, M.3
Eron, J.4
Jacobson, J.5
Arduino, R.6
Torriani, F.7
Deeks, S.8
Sereni, D.9
Sista, N.10
Harris, J.11
Bigley, J.12
Rousseau, F.13
|